Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
AAD Establishes Registry for Skin Manifestations of COVID-19
Initial study describes cutaneous involvement, which was reported in 20.4 percent of 88 patients
Mild, No Symptoms for Most Children With SARS-CoV-2 Infection
Main radiologic findings are bronchial thickening, ground-glass opacities; also seen when asymptomatic
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
White House Announces Payment Plan for Uninsured COVID-19 Patients
Doctors can submit bills for these patients directly to the government and be paid at Medicare rates
Scoring System Helps Guide Surgical Care During COVID-19
Twenty-one factors that were significant contributors to procedure triage and prioritization identified
Obesity Ups Risk for COVID-19 Severity
Disease severity increases with increasing body mass index
ST-Segment Elevation Described in Patients With COVID-19
Presentation variable with high prevalence of nonobstructive disease, poor prognosis
Expert Panel: There Are No Proven Drug Treatments for COVID-19
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
Rapid COVID-19 Test Can Produce False Negatives
Solutions known as 'viral transport media' should not be used for samples tested with the Abbott ID NOW device
